Serina Therapeutics, Inc. Warrants and Rights Outstanding
Serina Therapeutics, Inc. (SER) had Warrants and Rights Outstanding of $3.55 million as of 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2025-08-11
- 2025-06-30: Warrants and Rights Outstanding $3.55M.
- 2025-03-31: Warrants and Rights Outstanding $2.59M.
- 2024-12-31: Warrants and Rights Outstanding $3.58M.
- 2023-12-31: Warrants and Rights Outstanding $0.00.
| Period end | Warrants and Rights Outstanding | Warrants and Rights Outstanding as first filed |
|---|---|---|
| 2025-06-30 | $3.55M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $2.59M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $3.58M 10-Q · filed 2025-08-11 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-24 | |
| 2023-03-31 | $905.00K 10-Q · filed 2024-05-14 | $1.00M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.08M 10-Q · filed 2024-05-14 | $500.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $2.00M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.00M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $5.00M 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |